logo
  • Company Introduction
  • Research Content
  • News
  • Operating Objectives
  • Contact Us

EN

ZH

EN

  • Company Introduction
  • Research Content
  • News
  • Operating Objectives
  • Contact Us

ALL

media news

academic articles

[Commercial Times] Fecula Biotech Wins Outstanding Innovation Award
2025.07.08
Resistant Starch-Encapsulated Probiotics Attenuate Colorectal Cancer Cachexia and 5-Fluorouracil-Induced Microbial Dysbiosis
2024.06.28
Effects of Resistant-Starch-Encapsulated Probiotic Cocktail on Intestines Damaged by 5-Fluorouracil
2024.08.20
[Health & Medical Network] Taiwan Bio-Pharma Association Leads Cross-Border Medical Investment, Expanding Overseas Industry Opportunities
2024.05.24
[Analysis of Innovative Technologies] INNOZONE Special Report on Drug Development and Precision Therapy
2023.12.19
[Commercial Times] Fecula Biotech Wins National Innovation Award
2023.12.14
[Commercial Times] Fecula Biotech Focuses on Resistant Starch Encapsulation Technology
2023.10.19
© Fecula Biotech. All Rights Reserved. Website constructed by
澄交生技 Fecula Biotech

06-505-0511

service@fecula.com.tw

4 F.-1A, No. 25, Nanke 3rd Rd., Xinshi Dist., Tainan City 744094, Taiwan (R.O.C.)